Literature DB >> 20859339

Racial differences in patterns of care among medicaid-enrolled patients with breast cancer.

Gretchen Kimmick1, Fabian Camacho, Kristi Long Foley, Edward A Levine, Rajesh Balkrishnan, Roger Anderson.   

Abstract

PURPOSE: Suboptimal care among minority and low-income patients may explain poorer survival. There is little information describing patterns of health care in Medicaid-insured women with breast cancer in the United States. Using a previously created and validated database linking Medicaid claims and state-wide tumor registry data, we describe patterns of breast cancer care within a low-income population.
METHODS: Sample characteristics were described by frequencies and means. Logistic regressions were used to determine predictors of type of surgery, use of radiation therapy after breast-conserving surgery (BCS), and use of adjuvant chemotherapy.
RESULTS: The sample consisted of 974 women. The dataset included only white (58%) and black (42%) women. Sixty-seven percent were treated with mastectomy; 43% received adjuvant chemotherapy; and 67% of women receiving BCS received adjuvant radiation. In multivariate analysis, predictors of BCS were young age, black race, and smaller tumor size. Furthermore, there was a trend toward more black than white women with tumors 4 cm or larger having BCS (18% v 8%; P = .06). Race was not related to use of adjuvant radiation therapy after BCS or to use of adjuvant chemotherapy.
CONCLUSION: In this group of patients with breast cancer enrolled in Medicaid, black women were more likely than white women to have BCS. Race was not associated with adjuvant radiation therapy or chemotherapy use. Factors affecting the quality of care delivered to low-income and minority patients are complex, and better care lies in exploring areas that need improvement.

Entities:  

Year:  2006        PMID: 20859339      PMCID: PMC2793634          DOI: 10.1200/JOP.2006.2.5.205

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  58 in total

1.  Increasing trends in the use of breast-conserving surgery in California.

Authors:  C R Morris; R Cohen; R Schlag; W E Wright
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

2.  Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

Authors:  X Du; J S Goodwin
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

3.  Racial differences in breast carcinoma survival.

Authors:  S A Joslyn; M M West
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

4.  Survival differences in breast cancer among racial/ethnic groups: a population-based study.

Authors:  A Boyer-Chammard; T H Taylor; H Anton-Culver
Journal:  Cancer Detect Prev       Date:  1999

5.  Survival of women after breast conserving surgery for early stage breast cancer.

Authors:  Jean L Freeman; Ann B Nattinger; James S Goodwin
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

6.  Effects of health insurance and race on breast carcinoma treatments and outcomes.

Authors:  R G Roetzheim; E C Gonzalez; J M Ferrante; N Pal; D J Van Durme; J P Krischer
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

7.  The effect of less than definitive care on breast carcinoma recurrence and mortality.

Authors:  T L Lash; R A Silliman; E Guadagnoli; V Mor
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

8.  Race, socioeconomic status, and breast cancer treatment and survival.

Authors:  Cathy J Bradley; Charles W Given; Caralee Roberts
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

9.  Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.

Authors:  J M Brooks; E Chrischilles; S Scott; J Ritho; S Chen-Hardee
Journal:  Med Care       Date:  2000-11       Impact factor: 2.983

10.  Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery.

Authors:  A B Nattinger; R G Hoffmann; R T Kneusel; M M Schapira
Journal:  Lancet       Date:  2000-09-30       Impact factor: 79.321

View more
  9 in total

1.  Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

Authors:  Roger T Anderson; Cyllene R Morris; Gretchen Kimmick; Amy Trentham-Dietz; Fabian Camacho; Xiao-Cheng Wu; Susan A Sabatino; Steven T Fleming; Joseph Lipscomb
Journal:  Cancer       Date:  2014-11-04       Impact factor: 6.860

2.  Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.

Authors:  Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Lori A Pollack; A Blythe Ryerson; Kevin C Ward
Journal:  Breast Cancer Res Treat       Date:  2012-01-26       Impact factor: 4.872

3.  Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.

Authors:  Kathryn E Weaver; Fabian Camacho; Wenke Hwang; Roger Anderson; Gretchen Kimmick
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

4.  Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.

Authors:  Lu Zhang; Jessica King; Xiao-Cheng Wu; Mei-Chin Hsieh; Vivien W Chen; Qingzhao Yu; Elizabeth Fontham; Michelle Loch; Lori A Pollack; Tekeda Ferguson
Journal:  Cancer Epidemiol       Date:  2018-11-08       Impact factor: 2.984

5.  Adjuvant Radiation and Outcomes After Breast Conserving Surgery in Publicly Insured Patients.

Authors:  Gretchen G Kimmick; Fabian Camacho; Wenke Hwang; Heath Mackley; John Stewart; Roger T Anderson
Journal:  J Geriatr Oncol       Date:  2012-04-01       Impact factor: 3.599

6.  Treatment patterns among medicaid-eligible women with breast cancer in georgia: are patterns different under the breast and cervical cancer prevention and treatment act?

Authors:  E Kathleen Adams; Li-Nien Chien; Sheryl G A Gabram-Mendola
Journal:  J Oncol Pract       Date:  2012-01       Impact factor: 3.840

7.  Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.

Authors:  Gery P Guy; Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Kevin C Ward
Journal:  Health Serv Res       Date:  2014-12-10       Impact factor: 3.402

8.  Adjuvant hormonal therapy use among insured, low-income women with breast cancer.

Authors:  Gretchen Kimmick; Roger Anderson; Fabian Camacho; Monali Bhosle; Wenke Hwang; Rajesh Balkrishnan
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

9.  Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.

Authors:  Vanessa B Sheppard; Jun He; Arnethea Sutton; Lee Cromwell; Georges Adunlin; Teresa M Salgado; Dennis Tolsma; Martha Trout; Brandi E Robinson; Megan C Edmonds; Hayden B Bosworth; Mahlet G Tadesse
Journal:  J Manag Care Spec Pharm       Date:  2019-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.